Search This Blog

Tuesday, June 30, 2026

Unicycive gets CRL for oxylanthanum carbonate NDA over third-party manufacturing

 

Unicycive gets FDA Complete Response Letter for oxylanthanum carbonate NDA over third-party manufacturing deficiencies

  • FDA CRL cites unresolved deficiencies at a third-party manufacturing facility, requests no new efficacy or safety data.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)